Forbion Growth Opportunities Fund IV and Forbion Ventures Fund VIII
◆ Fund Size
$2.3B
◆ Location
Netherlands
◆ Portfolio
140 companies
◆ Activity
Statusactively investing
◆ Links
◆ Share this fund
◆ Investment Thesis
Forbion is a global venture capital firm dedicated to advancing groundbreaking biotech innovations and other sustainable solutions that improve the health of people and our planet. The firm invests in innovative biotech companies across all stages of (bio-)pharmaceutical drug development, from pre-creation and early-stage company building through clinical-stage growth capital. In addition, Forbion leverages its biotech expertise beyond human health to address planetary health challenges through its BioEconomy fund strategy, which invests in companies developing sustainable solutions in food, agriculture, materials, and environmental technologies.
◆ About Forbion
Two new life sciences venture capital funds. Forbion Growth Opportunities Fund IV targets later-stage biopharma companies in Europe and North America; Forbion Ventures Fund VIII invests in therapeutics-focused biotech companies at various stages.
◆ Sectors
◆ Stages
◆ Geography Focus
◆ Team
| Name | Title | Role | Links |
|---|---|---|---|
| Audrey Cacaly | — | Principal | |
| Carlo Incerti | — | Operating Partner | |
| Dirk Kersten | Managing Partner | — | |
| Martien van Osch | Managing Partner | — | |
| Nanna Lüneborg | General Partner | General Partner | |
| Robbert van de Griendt | General Partner, Investor Relations and Impact | — | |
| Sander Slootweg | — | Managing Partner |
◆ Notable Investments
◆ Traits
Leads rounds
Co-invests
◆ FAQ
What does Forbion Growth Opportunities Fund IV and Forbion Ventures Fund VIII invest in?
Forbion Growth Opportunities Fund IV and Forbion Ventures Fund VIII invests in Biotech, Drug Discovery and Medtech at the seed, series-a, series-b, series-c and growth stages.
Which geographies does Forbion Growth Opportunities Fund IV and Forbion Ventures Fund VIII focus on?
Forbion Growth Opportunities Fund IV and Forbion Ventures Fund VIII focuses on Europe and North America, and is headquartered in Netherlands.